Celsion logo

CLSN - Celsion News Story

$0.908 0.0  4.4%

Last Trade - 8:55pm

Sector
Healthcare
Size
Micro Cap
Market Cap £24.0m
Enterprise Value £14.2m
Revenue £368k
Position in Universe 5441st / 6554

BRIEF-Celsion Says Since April 27, A Total Of 14 New Deaths Have Been Reported In Optima Study

Mon 12th October, 2020 2:12pm
Oct 12 (Reuters) - Celsion Corp  CLSN.O :
    * CELSION CORP - SINCE APRIL 27, A TOTAL OF 14 NEW DEATHS
HAVE
BEEN REPORTED IN OPTIMA STUDY FIVE OF WHICH OCCURRED SINCE JULY
    * CELSION CORP - NOW HAVE A TOTAL OF 174 DEATHS IN OPTIMA
STUDY
FROM A TOTAL PATIENT ENROLLMENT OF 556
    * CELSION CORP - OPTIMA STUDY'S STATISTICAL PLAN SPECIFIES A
MINIMUM OF 197 DEATHS FOR FINAL DATA ANALYSIS
    * CELSION - IN PRELIMINARY EVALUATION OF TOPLINE DATA, CO
DETERMINED SHOULD CONTINUE TO FOLLOW PATIENTS UNTIL FUTILITY IS
EITHER CONFIRMED OR DISPELLED
    * CELSION CORP - HAS SUBMITTED ALL OPTIMA STUDY CLINICAL
TRIAL
DATA TO NATIONAL INSTITUTES OF HEALTH
    * CELSION CORP - NOTED A TIMED-BASED CHANGE IN DEATHS IN
THERMODOX
TREATMENT ARM SUGGESTED A PROPORTIONALITY ISSUE THAT REQUIRED
FURTHER EVALUATION
    * CELSION CORP - FIRMLY BELIEVE, THAT CO IS OBLIGATED TO
UNDERTAKE
RIGOROUS EVALUATION OF DATA WHILE CO CONTINUES TO FOLLOW
PATIENTS
    * CELSION CORP - CONTINUE TO ENROLL PATIENTS IN PHASE II
PORTION
OF OVATION 2 STUDY EVALUATING GEN-1 FOR TREATMENT OF ADVANCED
OVARIAN CANCER
    * CELSION CORP - EXPECT PATIENT ENROLLMENT IN OVATION 2
STUDY TO
BE COMPLETED BY END OF Q2 OF 2021

Source text for Eikon:  ID:nGNX5lWHGB 
Further company coverage:  CLSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.